ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

11,153Medicare Part D Prescriptions Filled, Including Refills

Rank: 420 out of 3734

$628K Total Retail Price of All Prescriptions

Rank: 430 out of 3734

275 Patients Receiving at Least One Drug in Part D
88%Patients 65 Years and Older
42% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Pennsylvania
Lower avg

Schedule Two
Controlled Substances

6% of this provider’s 275 patients filled at least one prescription for a schedule two drug, compared to an average of 6%.

Schedule Three
Controlled Substances

12% of this provider’s 275 patients filled at least one prescription for a schedule three drug, compared to an average of 8%.

Risky Drugs to Seniors

3% of this provider’s 10,302 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

25% of this provider’s prescriptions were for brand-name drugs, compared to an average of 24%.

Prescription Price

$56 was the average price of a prescription from this provider, compared to $57 among peers.

Prescriptions per Patient

41 is the average number of prescriptions (including refills) per patient, compared to an average of 19.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Pennsylvania
AMLODIPINE BESYLATE 535 507 1 5
METOPROLOL SUCCINATE 472 445 2 14
LISINOPRIL 381 344 3 3
CRESTOR 379 358 4 28
LEVOTHYROXINE SODIUM 356 352 5 2
OMEPRAZOLE 311 300 6 4
METOPROLOL TARTRATE 291 268 7 6
ATORVASTATIN CALCIUM 272 260 8 11
FUROSEMIDE 266 266 9 7
GLYBURIDE MICRONIZED 177 169 R 10 312
ENALAPRIL MALEATE 176 158 11 63
SIMVASTATIN 173 157 12 1
ALLOPURINOL 153 138 13 33
WARFARIN SODIUM 150 150 14 10
HYDROCHLOROTHIAZIDE 141 126 15 9
DONEPEZIL HCL 136 136 16 25
LOSARTAN POTASSIUM 123 111 17 21
HYDROCODONE-ACETAMINOPHEN 121 88 S3 18 12
PRAVASTATIN SODIUM 119 109 19 15
METFORMIN HCL 119 116 19 8
ALENDRONATE SODIUM 114 114 21 26
DIOVAN 112 112 22 31
RANITIDINE HCL 112 99 22 32
CLONIDINE HCL 111 81 24 79
JANUVIA 106 90 25 50
CLOPIDOGREL 101 101 26 23
CITALOPRAM HBR 96 76 27 16
ATENOLOL 93 93 28 13
ISOSORBIDE MONONITRATE ER 93 80 28 34
ZETIA 91 91 30 55
PAROXETINE HCL 90 80 31 59
GABAPENTIN 84 84 32 17
CELEBREX 81 79 33 69
NEXIUM 80 60 34 36
DIGOXIN 79 79 35 43
INDAPAMIDE 78 74 36 218
MELOXICAM 77 77 37 52
DIOVAN HCT 69 69 38 72
PANTOPRAZOLE SODIUM 69 52 38 22
SERTRALINE HCL 68 45 40 18
PLAVIX 66 66 41 39
TRAMADOL HCL 66 66 41 20
DOXAZOSIN MESYLATE 65 52 43 100
NITROGLYCERIN PATCH 63 63 44 171
CILOSTAZOL 62 62 45 301
KLOR-CON M10 62 62 45 115
ZOLPIDEM TARTRATE 60 37 47 24
GLIMEPIRIDE 58 56 48 37
METFORMIN HCL ER 57 43 49 66
LIPITOR 56 46 50 90
TAMSULOSIN HCL 55 55 51 29
NAMENDA 53 53 52 44
SPIRIVA 53 53 52 40
PROAIR HFA 53 48 52 83
VENLAFAXINE HCL ER 52 52 55 84
LISINOPRIL-HYDROCHLOROTHIAZIDE 51 51 56 27
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Jan. 25, 2011.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.